Working… Menu

Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes (REFORM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02397421
Recruitment Status : Completed
First Posted : March 25, 2015
Last Update Posted : July 31, 2018
European Foundation for the Study of Diabetes
Information provided by (Responsible Party):
Jagdeep Singh Surmukh Singh, University of Dundee